BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg HFL, Miller WL, Murad MH, Oberfield SE, White PC. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:4043-88. [PMID: 30272171 DOI: 10.1210/jc.2018-01865] [Cited by in Crossref: 272] [Cited by in F6Publishing: 224] [Article Influence: 90.7] [Reference Citation Analysis]
Number Citing Articles
1 Al Shaikh A, AlGhanmi Y, Awidah S, Bahha A, Ahmed ME, Soliman AT. Clinical Patterns and Linear Growth in Children with Congenital Adrenal Hyperplasia, an 11-Year Experience. Indian J Endocrinol Metab 2019;23:298-306. [PMID: 31641631 DOI: 10.4103/ijem.IJEM_99_19] [Reference Citation Analysis]
2 Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H. Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. BMC Endocr Disord 2020;20:165. [PMID: 33168061 DOI: 10.1186/s12902-020-00643-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Tolba A, Mandour I, Musa N, Elmougy F, Hafez M, Abdelatty S, Ibrahim A, Soliman H, Labib B, Elshiwy Y, Ramzy T, Elsharkawy M. Copy Number Variations in Genetic Diagnosis of Congenital Adrenal Hyperplasia Children. Front Genet 2022;13:785570. [DOI: 10.3389/fgene.2022.785570] [Reference Citation Analysis]
4 Lottspeich C, Müller-Lisse U, Seiler L, Schmitt-Graeff AH, Reincke M, Reisch N. Three Cases of Testicular Adrenal Rest Tumors in Congenital Adrenal Hyperplasia-A Diagnostic and Therapeutic Challenge. Urology 2019;129:24-8. [PMID: 30898461 DOI: 10.1016/j.urology.2019.03.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Borges JH, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM. Cardiovascular dysfunction risk in young adults with congenital adrenal hyperplasia caused by 21-hydroxylase enzyme deficiency. Int J Clin Pract 2021;75:e14233. [PMID: 33884716 DOI: 10.1111/ijcp.14233] [Reference Citation Analysis]
6 Choukair D, Hauck F, Bettendorf M, Krude H, Klein C, Bäumer T, Berner R, Lee-Kirsch MA, Grasemann C, Burgard P, Hoffmann GF. An Integrated clinical pathway for diagnosis, treatment and care of rare diseases: model, operating procedures, and results of the project TRANSLATE-NAMSE funded by the German Federal Joint Committee. Orphanet J Rare Dis 2021;16:474. [PMID: 34772435 DOI: 10.1186/s13023-021-02092-w] [Reference Citation Analysis]
7 Marshall DJ, Adaway JE, Hawley JM, Keevil BG. Quantification of testosterone, androstenedione and 17-hydroxyprogesterone in whole blood collected using Mitra microsampling devices. Ann Clin Biochem 2020;57:351-9. [PMID: 32524824 DOI: 10.1177/0004563220937735] [Reference Citation Analysis]
8 Perez MN, Delozier AM, Aston CE, Austin P, Baskin L, Chan YM, Cheng EY, Diamond DA, Fried A, Greenfield S, Kolon T, Kropp B, Lakshmanan Y, Meyer S, Meyer T, Nokoff N, Palmer B, Paradis A, Poppas D, Scott Reyes KJ, Swartz JM, Tishelman A, Wisniewski AB, Wolfe-Christensen C, Yerkes E, Mullins LL. Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development. J Urol 2019;202:1046-51. [PMID: 31268850 DOI: 10.1097/JU.0000000000000424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
9 Chawla R, Weidler EM, Hernandez J, Grimbsy G, van Leeuwen K. Utilization of a shared decision-making tool in a female infant with congenital adrenal hyperplasia and genital ambiguity. J Pediatr Endocrinol Metab 2019;32:643-6. [PMID: 31145695 DOI: 10.1515/jpem-2018-0567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Naiki Y, Fukami M. Letter to the Editor: "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab 2019;104:1926-7. [PMID: 30561707 DOI: 10.1210/jc.2018-02529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yeliosof O, Gangat M. Diagnosis and management of hypopituitarism. Curr Opin Pediatr 2019;31:531-6. [PMID: 31082937 DOI: 10.1097/MOP.0000000000000779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Walton JC, Walker WH 2nd, Bumgarner JR, Meléndez-Fernández OH, Liu JA, Hughes HL, Kaper AL, Nelson RJ. Circadian Variation in Efficacy of Medications. Clin Pharmacol Ther 2021;109:1457-88. [PMID: 33025623 DOI: 10.1002/cpt.2073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 de Miranda MC, Haddad LBP, Trindade E, Cassenote A, Hayashi GY, Damiani D, Costa FC, Madureira G, de Mendonca BB, Bachega TASS. The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts. Front Pediatr 2021;9:659492. [PMID: 34109139 DOI: 10.3389/fped.2021.659492] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zetterström RH, Karlsson L, Falhammar H, Lajic S, Nordenström A. Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Int J Neonatal Screen 2020;6:E71. [PMID: 33239597 DOI: 10.3390/ijns6030071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hirschberg AL, Gidlöf S, Falhammar H, Frisén L, Almqvist C, Nordenskjöld A, Nordenström A. Reproductive and Perinatal Outcomes in Women with Congenital Adrenal Hyperplasia: A Population-based Cohort Study. J Clin Endocrinol Metab 2021;106:e957-65. [PMID: 33135723 DOI: 10.1210/clinem/dgaa801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lasarev MR, Bialk ER, Allen DB, Held PK. Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020;105:dgaa371. [PMID: 32525982 DOI: 10.1210/clinem/dgaa371] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Saraf S, Srivastava P, Panigrahi I, Seenappa V, Kumar R, Yadav J, Daniel R, Dayal D. Characterization of the CYP21A2 Gene Mutations in Children with Classic Congenital Adrenal Hyperplasia. Indian J Pediatr. [DOI: 10.1007/s12098-021-03975-3] [Reference Citation Analysis]
18 AbdAlmageed W, Mirzaalian H, Guo X, Randolph LM, Tanawattanacharoen VK, Geffner ME, Ross HM, Kim MS. Assessment of Facial Morphologic Features in Patients With Congenital Adrenal Hyperplasia Using Deep Learning. JAMA Netw Open 2020;3:e2022199. [PMID: 33206189 DOI: 10.1001/jamanetworkopen.2020.22199] [Reference Citation Analysis]
19 Lao Q, Brookner B, Merke DP. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. J Mol Diagn 2019;21:924-31. [PMID: 31229653 DOI: 10.1016/j.jmoldx.2019.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
20 Chawla R, Rutter M, Green J, Weidler EM. Care of the adolescent patient with congenital adrenal hyperplasia: Special considerations, shared decision making, and transition. Semin Pediatr Surg 2019;28:150845. [PMID: 31668292 DOI: 10.1016/j.sempedsurg.2019.150845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Akbulut S, Ceylan SD, Tuncali T, Sogutcu N. Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal Hyperplasia, and Triple Translocation: Is a Consequence or Coincidence? J Gastrointest Cancer 2021;52:508-14. [PMID: 32388791 DOI: 10.1007/s12029-020-00408-w] [Reference Citation Analysis]
22 Bonfig W. 3 Wochen/m mit Erbrechen, Hypoglykämie und apathischem Zustand: Vorbereitung auf die Facharztprüfung: Fall 61. Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-022-01464-1] [Reference Citation Analysis]
23 Rege J, Turcu AF, Else T, Auchus RJ, Rainey WE. Steroid biomarkers in human adrenal disease. J Steroid Biochem Mol Biol 2019;190:273-80. [PMID: 30707926 DOI: 10.1016/j.jsbmb.2019.01.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
24 Seth A. Optimizing Stature in Congenital Adrenal Hyperplasia: Challenges and Solutions. Indian J Pediatr 2019;86:489-91. [DOI: 10.1007/s12098-019-02961-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Gomes LG, Bachega TA, Mendonca BB. Classic congenital adrenal hyperplasia and its impact on reproduction. Fertility and Sterility 2019;111:7-12. [DOI: 10.1016/j.fertnstert.2018.11.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
26 Wilson JB, Zopey M, Augustine J, Schaffer R, Chiang M, Friedman TC. High Prevalence of Adrenal Remnant Tissue in Patients Undergoing Bilateral Adrenalectomy for Cushing's Disease. Horm Metab Res 2021;53:161-8. [PMID: 33091942 DOI: 10.1055/a-1253-2854] [Reference Citation Analysis]
27 Abdelmeguid Y, Yakout N, Oshiba A, Zain M, Kotb M. Huge ovarian cyst in a neonate with classical 21-hydroxylase deficiency. Clin Pediatr Endocrinol 2021;30:57-60. [PMID: 33446954 DOI: 10.1297/cpe.30.57] [Reference Citation Analysis]
28 Travers S, Bouvattier C, Fagart J, Martinerie L, Viengchareun S, Pussard E, Lombès M. Interaction between accumulated 21-deoxysteroids and mineralocorticoid signaling in 21-hydroxylase deficiency. American Journal of Physiology-Endocrinology and Metabolism 2020;318:E102-10. [DOI: 10.1152/ajpendo.00368.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Baskin L, Derpinghaus A, Cao M, Sinclair A, Li Y, Overland M, Cunha GR. Hot spots in fetal human penile and clitoral development. Differentiation 2020;112:27-38. [PMID: 31874420 DOI: 10.1016/j.diff.2019.11.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Heath C, Siafarikas A, Sommerfield A, von Ungern-Sternberg BS. Peri-operative steroid management in the paediatric population. Acta Anaesthesiol Scand 2021;65:1187-94. [PMID: 34263943 DOI: 10.1111/aas.13952] [Reference Citation Analysis]
31 Arriba M, Ezquieta B. Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach. Front Endocrinol 2022;13:834549. [DOI: 10.3389/fendo.2022.834549] [Reference Citation Analysis]
32 Cohen M, Pignatti E, Dines M, Mory A, Ekhilevitch N, Kolodny R, Flück CE, Tiosano D. In Silico Structural and Biochemical Functional Analysis of a Novel CYP21A2 Pathogenic Variant. Int J Mol Sci 2020;21:E5857. [PMID: 32824094 DOI: 10.3390/ijms21165857] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 La B, Tung C, Choi EA, Nguyen H. A Gigantic Uterine Leiomyoma and Big Bilateral Adrenal Myelolipomas as a Result of Untreated Congenital Adrenal Hyperplasia. AACE Clin Case Rep 2021;7:342-5. [PMID: 34765728 DOI: 10.1016/j.aace.2021.05.002] [Reference Citation Analysis]
34 Rosli NA, Mazapuspavina MY, Mohd Nor NS. Congenital Adrenal Hyperplasia: Diagnostic Pitfalls in Prolonged Neonatal Jaundice. Clin Pract 2021;11:870-7. [PMID: 34842633 DOI: 10.3390/clinpract11040102] [Reference Citation Analysis]
35 de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand. Clin Endocrinol (Oxf) 2021;94:904-12. [PMID: 33471388 DOI: 10.1111/cen.14422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Al Alawi AM, Nordenström A, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency. Endocrine 2019;63:407-21. [PMID: 30719691 DOI: 10.1007/s12020-018-01835-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
37 . Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789. Obstet Gynecol 2019;134:e106-14. [PMID: 31568365 DOI: 10.1097/AOG.0000000000003475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
38 Farghaly HS, Metwalley KA, Raafat DM, Saied GM, Gabri MF, Algowhary M. Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic congenital adrenal hyperplasia. Atherosclerosis 2021;328:38-43. [PMID: 34091068 DOI: 10.1016/j.atherosclerosis.2021.05.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Pitsava G, Stratakis CA. Adrenal hyperplasias in childhood: An update. Front Endocrinol 2022;13:937793. [DOI: 10.3389/fendo.2022.937793] [Reference Citation Analysis]
40 Martinez de LaPiscina I, Flück CE. Genetics of human sexual development and related disorders. Curr Opin Pediatr 2021;33:556-63. [PMID: 34654048 DOI: 10.1097/MOP.0000000000001066] [Reference Citation Analysis]
41 Wisniewski AB, Batista RL, Costa EMF, Finlayson C, Sircili MHP, Dénes FT, Domenice S, Mendonca BB. Management of 46,XY Differences/Disorders of Sex Development (DSD) Throughout Life. Endocr Rev 2019;40:1547-72. [PMID: 31365064 DOI: 10.1210/er.2019-00049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
42 Schröder MAM, Claahsen-van der Grinten HL. Novel treatments for congenital adrenal hyperplasia. Rev Endocr Metab Disord 2022. [PMID: 35199280 DOI: 10.1007/s11154-022-09717-w] [Reference Citation Analysis]
43 Torky A, Sinaii N, Jha S, Desai J, El-Maouche D, Mallappa A, Merke DP. Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021;106:e5247-57. [PMID: 33677504 DOI: 10.1210/clinem/dgab133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Saito J, Yoshikawa N, Hanawa T, Ozawa A, Matsumoto T, Harada T, Iwahashi K, Nakamura H, Yamatani A. Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan. Pharmaceutics 2021;13:1267. [PMID: 34452228 DOI: 10.3390/pharmaceutics13081267] [Reference Citation Analysis]
45 Al-Kofahi M, Ahmed MA, Jaber MM, Tran TN, Willis BA, Zimmerman CL, Gonzalez-Bolanos MT, Brundage RC, Sarafoglou K. An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia. Br J Clin Pharmacol 2021;87:1098-110. [PMID: 32652643 DOI: 10.1111/bcp.14470] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Wijaya M, Ma H, Zhang J, Du M, Li Y, Chen Q, Guo S. Aldosterone signaling defect in young infants: single-center report and review. BMC Endocr Disord 2021;21:149. [PMID: 34243750 DOI: 10.1186/s12902-021-00811-9] [Reference Citation Analysis]
47 Ilany J, Cohen O. Assessing the risk of having a child with classic 21-hydroxylase deficiency: a new paradigm. Trends Endocrinol Metab 2021;32:423-32. [PMID: 33994073 DOI: 10.1016/j.tem.2021.04.007] [Reference Citation Analysis]
48 Ozdemir Dilek S, Turan I, Gurbuz F, Celiloglu C, Yuksel B. The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency. Hormones (Athens) 2022. [PMID: 35243601 DOI: 10.1007/s42000-022-00354-1] [Reference Citation Analysis]
49 Capalbo D, Moracas C, Cappa M, Balsamo A, Maghnie M, Wasniewska MG, Greggio NA, Baronio F, Bizzarri C, Ferro G, Di Lascio A, Stancampiano MR, Azzolini S, Patti G, Longhi S, Valenzise M, Radetti G, Betterle C, Russo G, Salerno M. Primary Adrenal Insufficiency in Childhood: Data From a Large Nationwide Cohort. J Clin Endocrinol Metab 2021;106:762-73. [PMID: 33247909 DOI: 10.1210/clinem/dgaa881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Baskin L, Cao M, Sinclair A, Li Y, Overland M, Isaacson D, Cunha GR. Androgen and estrogen receptor expression in the developing human penis and clitoris. Differentiation 2020;111:41-59. [PMID: 31655443 DOI: 10.1016/j.diff.2019.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
51 Buonocore F, McGlacken-Byrne SM, Del Valle I, Achermann JC. Current Insights Into Adrenal Insufficiency in the Newborn and Young Infant. Front Pediatr 2020;8:619041. [PMID: 33381483 DOI: 10.3389/fped.2020.619041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
52 Reisch N. Block and Replace-a New Therapeutic Concept in Congenital Adrenal Hyperplasia? J Clin Endocrinol Metab 2022;107:e423-5. [PMID: 34331764 DOI: 10.1210/clinem/dgab555] [Reference Citation Analysis]
53 Stambough K, Magistrado L, Perez-Milicua G. Evaluation of ambiguous genitalia. Curr Opin Obstet Gynecol 2019;31:303-8. [PMID: 31425174 DOI: 10.1097/GCO.0000000000000565] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kocova M, Concolino P, Falhammar H. Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Front Endocrinol 2022;12:788812. [DOI: 10.3389/fendo.2021.788812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Gao Y, Lu L, Yu B, Mao J, Wang X, Nie M, Wu X. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 2020;105:dgaa199. [PMID: 32291442 DOI: 10.1210/clinem/dgaa199] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
56 Cussen L, McDonnell T, Bennett G, Thompson CJ, Sherlock M, O'Reilly MW. Approach to androgen excess in women: Clinical and biochemical insights. Clin Endocrinol (Oxf) 2022. [PMID: 35349173 DOI: 10.1111/cen.14710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kolli V, da Cunha IW, Kim S, Iben JR, Mallappa A, Li T, Gaynor A, Coon SL, Quezado MM, Merke DP. Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2021;12:730947. [PMID: 34616364 DOI: 10.3389/fendo.2021.730947] [Reference Citation Analysis]
58 Itonaga T, Izawa M, Hamajima T, Hasegawa Y. First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency. Front Endocrinol 2022;12:808254. [DOI: 10.3389/fendo.2021.808254] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Itonaga T, Akiba K, Hasegawa Y. Therapeutic needs from early childhood in four patients with 21-hydroxylase deficiency harboring the P30L mutation on one allele. Clin Pediatr Endocrinol 2021;30:187-93. [PMID: 34629741 DOI: 10.1297/cpe.30.187] [Reference Citation Analysis]
60 Fox DA, Ronsley R, Khowaja AR, Haim A, Vallance H, Sinclair G, Amed S. Clinical Impact and Cost Efficacy of Newborn Screening for Congenital Adrenal Hyperplasia. J Pediatr 2020;220:101-108.e2. [PMID: 32044100 DOI: 10.1016/j.jpeds.2019.12.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
61 Sumińska M, Bogusz-Górna K, Wegner D, Fichna M. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report. Int J Mol Sci 2020;21:E4622. [PMID: 32610579 DOI: 10.3390/ijms21134622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
62 Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, Lindén Hirschberg A, Juul A, Newell-Price J, Perry CG, Prete A, Rees DA, Reisch N, Stikkelbroeck N, Touraine P, Maltby K, Treasure FP, Porter J, Ross RJ. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021;106:e2063-77. [PMID: 33527139 DOI: 10.1210/clinem/dgab051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Luo X, Sun Y, Xu F, Guo J, Li L, Lin Z, Ye J, Gu X, Yu Y. A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns. Ann Transl Med 2020;8:1058. [PMID: 33145277 DOI: 10.21037/atm-20-1147] [Reference Citation Analysis]
64 Gardner M, Sandberg DE. Navigating Surgical Decision Making in Disorders of Sex Development (DSD). Front Pediatr 2018;6:339. [PMID: 30510925 DOI: 10.3389/fped.2018.00339] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
65 Regelmann MO, Conroy R, Gourgari E, Gupta A, Guttmann-Bauman I, Heksch R, Kamboj MK, Krishnan S, Lahoti A, Matlock K; PES Drug and Therapeutics Committee and Practice Management Committee. Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions. Horm Res Paediatr 2020;93:343-50. [PMID: 33486483 DOI: 10.1159/000513060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
66 Sarafoglou K, Barnes CN, Huang M, Imel EA, Madu IJ, Merke DP, Moriarty D, Nakhle S, Newfield RS, Vogiatzi MG, Auchus RJ. Tildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies. J Clin Endocrinol Metab 2021:dgab438. [PMID: 34146101 DOI: 10.1210/clinem/dgab438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Marino R, Moresco A, Perez Garrido N, Ramirez P, Belgorosky A. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome. Front Endocrinol 2022;13:803226. [DOI: 10.3389/fendo.2022.803226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Khattab A, Marshall I. Management of congenital adrenal hyperplasia: beyond conventional glucocorticoid therapy. Curr Opin Pediatr 2019;31:550-4. [PMID: 31295195 DOI: 10.1097/MOP.0000000000000780] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
69 Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, Guan Q, Zhou X, Zheng D, Li G, Zhao J. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency. Mol Genet Genomic Med 2019;7:e671. [PMID: 30968594 DOI: 10.1002/mgg3.671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
70 Maffazioli GDN, Bachega TASS, Hayashida SAY, Gomes LG, Valassi HPL, Marcondes JAM, Mendonca BB, Baracat EC, Maciel GAR. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2020;105:dgaa369. [PMID: 32530459 DOI: 10.1210/clinem/dgaa369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sweeney AT, Srivoleti P, Blake MA. Management of the patient with incidental bilateral adrenal nodules. Journal of Clinical and Translational Endocrinology: Case Reports 2021;20:100082. [DOI: 10.1016/j.jecr.2021.100082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Di Luigi L, Pigozzi F, Sgrò P, Frati L, Di Gianfrancesco A, Cappa M. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology. J Endocrinol Invest 2020;43:563-73. [PMID: 31734891 DOI: 10.1007/s40618-019-01145-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
73 Riedl S, Röhl FW, Bonfig W, Brämswig J, Richter-Unruh A, Fricke-Otto S, Bettendorf M, Riepe F, Kriegshäuser G, Schönau E, Even G, Hauffa B, Dörr HG, Holl RW, Mohnike K; AQUAPE CAH Study Group. Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients. Endocr Connect 2019;8:86-94. [PMID: 30620712 DOI: 10.1530/EC-18-0281] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
74 Kudela G, Gawlik A, Koszutski T. Early Feminizing Genitoplasty in Girls with Congenital Adrenal Hyperplasia (CAH)-Analysis of Unified Surgical Management. Int J Environ Res Public Health 2020;17:E3852. [PMID: 32485822 DOI: 10.3390/ijerph17113852] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 Estermann MA, Smith CA. Applying Single-Cell Analysis to Gonadogenesis and DSDs (Disorders/Differences of Sex Development). Int J Mol Sci 2020;21:E6614. [PMID: 32927658 DOI: 10.3390/ijms21186614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Piskinpasa H, Ciftci Dogansen S, Kusku Cabuk F, Guzey D, Sahbaz NA, Akdeniz YS, Mert M. BILATERAL ADRENAL AND TESTICULAR MASS IN A PATIENT WITH CONGENITAL ADRENAL HYPERPLASIA. Acta Endocrinol (Buchar) 2019;-5:113-7. [PMID: 31149069 DOI: 10.4183/aeb.2019.113] [Reference Citation Analysis]
77 Wei R, Bowers K, Kroner GM, Payto D, Colón-franco JM. The Androstenedione Roche Elecsys immunoassay has superior comparability to the LC-MS/MS assay than the Siemens Immulite immunoassay. Practical Laboratory Medicine 2022. [DOI: 10.1016/j.plabm.2022.e00279] [Reference Citation Analysis]
78 Lao Q, Jardin MD, Jayakrishnan R, Ernst M, Merke DP. Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Genet 2018;137:955-60. [PMID: 30465166 DOI: 10.1007/s00439-018-1959-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
79 Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020;105:dgaa071. [PMID: 32052005 DOI: 10.1210/clinem/dgaa071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
80 Engberg H, Möller A, Hagenfeldt K, Nordenskjöld A, Frisén L. Identity, Sexuality, and Parenthood in Women with Congenital Adrenal Hyperplasia. J Pediatr Adolesc Gynecol 2020;33:470-6. [PMID: 32473322 DOI: 10.1016/j.jpag.2020.05.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Fouques C, Fatfouta I, Hieronimus S, Sadoul JL, Bongain A. Two cases of male patients followed for a classical form of congenital adrenal hyperplasia (CAH), presenting an azoospermia: analysis and review of the literature. Basic Clin Androl 2019;29:10. [PMID: 31143447 DOI: 10.1186/s12610-019-0084-8] [Reference Citation Analysis]
82 Robinson DA, Kemeny M, Muchinyi JE, Yasin M, Montes NI, Tuli S, Jaiswal R, Carter A, Derezil M, Jang H, Reich D, Moore WV. Adrenal Myelolipoma Masquerading as an Adrenal Malignancy. Case Reports in Endocrinology 2022;2022:1-7. [DOI: 10.1155/2022/4044602] [Reference Citation Analysis]
83 Rosenfield RL. Normal and Premature Adrenarche. Endocr Rev 2021:bnab009. [PMID: 33788946 DOI: 10.1210/endrev/bnab009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
84 Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med 2020;13:62-9. [PMID: 32714437 DOI: 10.1177/1753495X19847832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
85 Chesover AD, Millar H, Sepiashvili L, Adeli K, Palmert MR, Hamilton J. Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry. J Endocr Soc 2020;4:bvz030. [PMID: 32110745 DOI: 10.1210/jendso/bvz030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Pode-Shakked N, Blau A, Pode-Shakked B, Tiosano D, Weintrob N, Eyal O, Zung A, Levy-Khademi F, Tenenbaum-Rakover Y, Zangen D, Gillis D, Pinhas-Hamiel O, Loewenthal N, de Vries L, Landau Z, Rachmiel M, Abu-Libdeh A, Eliakim A, Strich D, Koren I, German A, Sack J, Almashanu S. Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2019;104:3172-80. [PMID: 30865229 DOI: 10.1210/jc.2018-02468] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
87 Tsuji-Hosokawa A, Kashimada K. Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan. Int J Neonatal Screen 2021;7:36. [PMID: 34209888 DOI: 10.3390/ijns7030036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Reisch N. Pregnancy in Congenital Adrenal Hyperplasia. Endocrinology and Metabolism Clinics of North America 2019;48:619-41. [DOI: 10.1016/j.ecl.2019.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Wall E, Aksglaede L, Haahr ME, Christiansen P, Main KM. Non-Classic Congenital Adrenal Hyperplasia in Two Adolescents With Gender Dysphoria. Journal of Psychosexual Health 2021;3:275-9. [DOI: 10.1177/26318318211028722] [Reference Citation Analysis]
90 Hines M. Human gender development. Neurosci Biobehav Rev 2020;118:89-96. [PMID: 32707345 DOI: 10.1016/j.neubiorev.2020.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
91 Delai A, Gomes PM, Foss-Freitas MC, Elias J, Antonini SR, Castro M, Moreira AC, Mermejo LM. Hyperinsulinemic-euglycaemic clamp strengthens the insulin resistance in nonclassical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2021:dgab767. [PMID: 34693966 DOI: 10.1210/clinem/dgab767] [Reference Citation Analysis]
92 Miclea D, Alkhzouz C, Bucerzan S, Grigorescu-Sido P. Genetic testing in pediatric endocrine pathology. Med Pharm Rep 2021;94:S15-8. [PMID: 34527901 DOI: 10.15386/mpr-2220] [Reference Citation Analysis]
93 Xu L, Lin W, Cai L, Huang H, Liang J, Li L, Zong L, Wang N, Wen J, Chen G. Efficacy and safety of prenatal dexamethasone treatment in offspring at risk for congenital adrenal hyperplasia due to 21‐hydroxylase deficiency: A systematic review and meta‐analysis. Clin Endocrinol 2020;92:109-23. [DOI: 10.1111/cen.14126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
94 Baskin A, Wisniewski AB, Aston CE, Austin P, Chan YM, Cheng EY, Diamond DA, Fried A, Kolon T, Lakshmanan Y, Williot P, Meyer S, Meyer T, Kropp B, Nokoff N, Palmer B, Paradis A, Poppas D, VanderBrink B, Scott Reyes KJ, Tishelman A, Wolfe-Christensen C, Yerkes E, Mullins LL, Baskin L. Post-operative complications following feminizing genitoplasty in moderate to severe genital atypia: Results from a multicenter, observational prospective cohort study. J Pediatr Urol 2020;16:568-75. [PMID: 32624410 DOI: 10.1016/j.jpurol.2020.05.166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
95 El-Maouche D, Merke DP, Vogiatzi MG, Chang AY, Turcu AF, Joyal EG, Lin VH, Weintraub L, Plaunt MR, Mohideen P, Auchus RJ. A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020;105:dgaa381. [PMID: 32589738 DOI: 10.1210/clinem/dgaa381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
96 Kolli V, Kim H, Rao H, Lao Q, Gaynor A, Milner JD, Merke DP. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. BMC Res Notes 2019;12:711. [PMID: 31666125 DOI: 10.1186/s13104-019-4753-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
97 Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H. Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba. Int J Endocrinol 2021;2021:9316284. [PMID: 33505466 DOI: 10.1155/2021/9316284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Corcioni B, Renzulli M, Marasco G, Baronio F, Gambineri A, Ricciardi D, Ortolano R, Farina D, Gaudiano C, Cassio A, Pagotto U, Golfieri R. Prevalence and ultrasound patterns of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia. Transl Androl Urol 2021;10:562-73. [PMID: 33718059 DOI: 10.21037/tau-20-998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Badeghiesh A, Ismail S, Baghlaf H, Suarthana E, Dahan MH. Pregnancy, delivery and neonatal outcomes among women with congenital adrenal hyperplasia: a study of a large US database. Reprod Biomed Online 2020;41:1093-9. [PMID: 33008769 DOI: 10.1016/j.rbmo.2020.08.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Close S, Talboy A. Congenital adrenal hyperplasia in a child with 47, XYY: Case report. J Pediatr Nurs 2022;65:127-8. [PMID: 35764369 DOI: 10.1016/j.pedn.2022.06.002] [Reference Citation Analysis]
101 Arshad MF, Debono M. Current and future treatment options for adrenal insufficiency. Curr Opin Endocrinol Diabetes Obes 2021;28:303-11. [PMID: 33782339 DOI: 10.1097/MED.0000000000000637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
102 Délot EC, Vilain E. Towards improved genetic diagnosis of human differences of sex development. Nat Rev Genet 2021;22:588-602. [PMID: 34083777 DOI: 10.1038/s41576-021-00365-5] [Reference Citation Analysis]
103 Chrisp GL, Torpy DJ, Maguire AM, Quartararo M, Falhammar H, King BR, Munns CF, Hameed S, Rushworth RL. The effect of patient-managed stress dosing on electrolytes and blood pressure in acute illness in children with adrenal insufficiency. Clin Endocrinol (Oxf) 2020;93:97-103. [PMID: 32301148 DOI: 10.1111/cen.14196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
104 Musa N, Asem N, Basyony S, Fawaz L. Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2020;33:295-304. [PMID: 32004147 DOI: 10.1515/jpem-2019-0345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
105 Kim HJ. Response to Apóstolos et al.’s (2018) “Gender Identity and Sexual Function in 46,XX Patients with Congenital Adrenal Hyperplasia Raised as Males”. Arch Sex Behav 2019;48:675-7. [DOI: 10.1007/s10508-018-1386-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
106 Li Z, Liang Y, Du C, Yu X, Hou L, Wu W, Ying Y, Luo X. Clinical applications of genetic analysis and liquid chromatography tandem-mass spectrometry in rare types of congenital adrenal hyperplasia. BMC Endocr Disord 2021;21:237. [PMID: 34823514 DOI: 10.1186/s12902-021-00901-8] [Reference Citation Analysis]
107 Grosse SD, Van Vliet G. Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia. Int J Neonatal Screen 2020;6:E82. [PMID: 33239603 DOI: 10.3390/ijns6040082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Van't Westeinde A, Zimmermann M, Messina V, Karlsson L, Padilla N, Lajic S. First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults. J Clin Endocrinol Metab 2020;105:dgaa611. [PMID: 32869847 DOI: 10.1210/clinem/dgaa611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Kim MS, Fraga NR, Minaeian N, Geffner ME. Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia. Front Endocrinol 2022;13:848274. [DOI: 10.3389/fendo.2022.848274] [Reference Citation Analysis]
110 Coope H, Parviainen L, Withe M, Porter J, Ross RJ. Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency. Expert Opinion on Orphan Drugs 2021;9:67-76. [DOI: 10.1080/21678707.2021.1903871] [Reference Citation Analysis]
111 Speiser PW. Emerging medical therapies for congenital adrenal hyperplasia. F1000Res 2019;8:363. [PMID: 30984389 DOI: 10.12688/f1000research.17778.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
112 de Oliveira DM, Vasques ACJ, Gonçalves EM, de Lemos-Marini SHV, Guerra-Junior G, Geloneze B. ENERGY EXPENDITURE IN 21-HYDROXYLASE CONGENITAL ADRENAL HYPERPLASIA PATIENTS AND COMPARISON WITH PREDICTIVE EQUATIONS. Endocr Pract 2020;26:388-98. [PMID: 31859548 DOI: 10.4158/EP-2019-0390] [Reference Citation Analysis]
113 Auer MK, Paizoni L, Neuner M, Lottspeich C, Schmidt H, Bidlingmaier M, Hawley J, Keevil B, Reisch N. 11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 2021;212:105921. [PMID: 34058329 DOI: 10.1016/j.jsbmb.2021.105921] [Reference Citation Analysis]
114 Rushworth RL, Torpy DJ, Falhammar H. Adrenal crises in older patients. Lancet Diabetes Endocrinol 2020;8:628-39. [PMID: 32559478 DOI: 10.1016/S2213-8587(20)30122-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
115 Xia J, Liu F, Wu J, Xia Y, Zhao Z, Zhao Y, Ren H, Kong X. Clinical and Genetic Characteristics of 17 α-Hydroxylase/17, 20-Lyase Deficiency: c.985_987delTACinsAA Mutation of CYP17A1 Prevalent in the Chinese Han Population. Endocr Pract 2021;27:137-45. [PMID: 33547012 DOI: 10.4158/EP-2020-0478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Ljubicic ML, Madsen A, Juul A, Almstrup K, Johannsen TH. The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2021;12:652888. [PMID: 34531821 DOI: 10.3389/fendo.2021.652888] [Reference Citation Analysis]
117 Dwiggins M, Brookner B, Fowler K, Veeraraghavan P, Gomez-Lobo V, Merke DP. Multidimensional Aspects of Female Sexual Function in Congenital Adrenal Hyperplasia: A Case-Control Study. J Endocr Soc 2020;4:bvaa131. [PMID: 34485799 DOI: 10.1210/jendso/bvaa131] [Reference Citation Analysis]
118 Costa-Barbosa FA, Carvalho VM, Oliveira KC, Vieira JGH, Kater CE. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects. Clin Endocrinol (Oxf) 2021. [PMID: 34231242 DOI: 10.1111/cen.14550] [Reference Citation Analysis]
119 Turcu AF, Mallappa A, Nella AA, Chen X, Zhao L, Nanba AT, Byrd JB, Auchus RJ, Merke DP. 24-Hour Profiles of 11-Oxygenated C19 Steroids and Δ5-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency. Front Endocrinol (Lausanne) 2021;12:751191. [PMID: 34867794 DOI: 10.3389/fendo.2021.751191] [Reference Citation Analysis]
120 Yoo HW. Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age. Ann Pediatr Endocrinol Metab 2021;26:149-57. [PMID: 34610702 DOI: 10.6065/apem.2142150.075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Segev-Becker A, Jacobson R, Stein R, Eyal O, Oren A, Schachter-Davidov A, Israeli G, Lebenthal Y, Weintrob N. WOMEN WITH NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA HAVE GENDER, SEXUALITY, AND QUALITY-OF-LIFE FEATURES SIMILAR TO THOSE OF NONAFFECTED WOMEN. Endocr Pract 2020;26:535-42. [PMID: 31968200 DOI: 10.4158/EP-2019-0509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
122 Miranda MC, Haddad LBP, Madureira G, Mendonca BB, Bachega TASS. Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence. J Endocr Soc 2020;4:bvz013. [PMID: 32047870 DOI: 10.1210/jendso/bvz013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
123 Oriolo C, Fanelli F, Castelli S, Mezzullo M, Altieri P, Corzani F, Pelusi C, Repaci A, Di Dalmazi G, Vicennati V, Baldazzi L, Menabò S, Dormi A, Nardi E, Brillanti G, Pasquali R, Pagotto U, Gambineri A. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone. J Endocrinol Invest 2020;43:1499-509. [PMID: 32236851 DOI: 10.1007/s40618-020-01235-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
124 Seraphim CE, Frassei JS, Pessoa BS, Scalco RC, Miranda MC, Madureira G, Mendonca BB, Bachega TASS. Impact of Long-Term Dexamethasone Therapy on the Metabolic Profile of Patients With 21-Hydroxylase Deficiency. J Endocr Soc 2019;3:1574-82. [PMID: 31384718 DOI: 10.1210/js.2019-00123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Nordenström A, Svensson J, Lajic S, Frisén L, Nordenskjöld A, Norrby C, Almqvist C, Falhammar H. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study. J Clin Endocrinol Metab 2019;104:6148-54. [PMID: 31393570 DOI: 10.1210/jc.2019-01199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Reeves PT, Packett AC, Burklow CS, Echelmeyer S, Larson NS. Development and assessment of a low-health-literacy, pictographic adrenal insufficiency action plan. J Pediatr Endocrinol Metab 2021. [PMID: 34592068 DOI: 10.1515/jpem-2021-0541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
127 Calissendorff J, Juhlin CC, Sundin A, Bancos I, Falhammar H. Adrenal myelolipomas. Lancet Diabetes Endocrinol 2021;9:767-75. [PMID: 34450092 DOI: 10.1016/S2213-8587(21)00178-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
128 Arteaga E, Valenzuela F, Lagos CF, Lagos M, Martinez A, Baudrand R, Carvajal C, Fardella CE. Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia. Endocrine 2020;67:258-63. [PMID: 31571129 DOI: 10.1007/s12020-019-02097-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Bonner JJ, Burt H, Johnson TN, Whitaker MJ, Porter J, Ross RJ. Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency. Eur J Pharm Sci 2021;165:105913. [PMID: 34146682 DOI: 10.1016/j.ejps.2021.105913] [Reference Citation Analysis]
130 Kienitz T, Schwander J, Bogner U, Schwabe M, Steinmüller T, Quinkler M. Giant bilateral adrenal lipoma in a patient with congenital adrenal hyperplasia. Endocrinol Diabetes Metab Case Rep 2021;2021:EDM200204. [PMID: 33845451 DOI: 10.1530/EDM-20-0204] [Reference Citation Analysis]
131 Haddad NG, Eugster EA. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes. Best Practice & Research Clinical Endocrinology & Metabolism 2019;33:101273. [DOI: 10.1016/j.beem.2019.04.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
132 Dörr HG, Oppelt PG. Genotyp-Phänotyp-Korrelation bei Zwillingsmädchen mit nichtklassischem adrenogenitalem Syndrom und 21-Hydroxylase-Defekt. Gynäkologische Endokrinologie 2020;18:123-8. [DOI: 10.1007/s10304-020-00303-4] [Reference Citation Analysis]
133 Messina V, Hirvikoski T, Karlsson L, Vissani S, Wallensteen L, Ortolano R, Balsamo A, Nordenström A, Lajic S. Good overall behavioural adjustment in children and adolescents with classic congenital adrenal hyperplasia. Endocrine 2020;68:427-37. [PMID: 32152914 DOI: 10.1007/s12020-020-02244-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
134 Santi M, Graf S, Zeino M, Cools M, Van De Vijver K, Trippel M, Aliu N, Flück CE. Approach to the Virilizing Girl at Puberty. J Clin Endocrinol Metab 2021;106:1530-9. [PMID: 33367768 DOI: 10.1210/clinem/dgaa948] [Reference Citation Analysis]
135 Gaudino R, Pecoraro L, Martini L, Salvottini C, Antoniazzi F, Piacentini G, Cavarzere P. 21-hydroxylase-deficient congenital adrenal hyperplasia classic form therapy knowledge and management: targeted educational intervention for pediatricians. Minerva Pediatr (Torino) 2021;73:285-7. [PMID: 32241101 DOI: 10.23736/S2724-5276.20.05594-2] [Reference Citation Analysis]
136 Wallensteen L, Karlsson L, Messina V, Nordenström A, Lajic S. Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH. J Clin Endocrinol Metab 2020;105:dgaa280. [PMID: 32433752 DOI: 10.1210/clinem/dgaa280] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Liu Y, Zheng J, Liu N, Xu X, Zhang X, Zhang Y, Li G, Liu G, Cai C, Shu J. The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort. Mol Genet Genomic Med 2020;8:e1501. [PMID: 32959514 DOI: 10.1002/mgg3.1501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Turan I, Tastan M, Boga DD, Gurbuz F, Kotan LD, Tuli A, Yüksel B. 21-Hydroxylase deficiency: Mutational spectrum and Genotype-Phenotype relations analyses by next-generation sequencing and multiplex ligation-dependent probe amplification. Eur J Med Genet 2020;63:103782. [PMID: 31586465 DOI: 10.1016/j.ejmg.2019.103782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
139 Bonfig W, Kapelari K, Riedl S. Therapie des klassischen 21‑Hydroxylase-Mangel-Adrenogenitalen Syndroms (AGS) im Kindes- und Jugendalter. J Klin Endokrinol Stoffw 2019;12:137-40. [DOI: 10.1007/s41969-019-00083-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
140 Miller BS, Spencer SP, Geffner ME, Gourgari E, Lahoti A, Kamboj MK, Stanley TL, Uli NK, Wicklow BA, Sarafoglou K. Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J Investig Med 2020;68:16-25. [PMID: 30819831 DOI: 10.1136/jim-2019-000999] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
141 Vora KA, Hanna CA, Neville KA, Bergman PB, Grover SR, O'Connell MA, Srinivasan S. Role of cross-campus multidisciplinary team meetings in decision-making for children and adolescents with differences of sex development/intersex. J Paediatr Child Health 2021;57:1402-7. [PMID: 33928709 DOI: 10.1111/jpc.15474] [Reference Citation Analysis]
142 Gao J, Chen L. Primary Adrenocortical Insufficiency Case Series in the Neonatal Period: Genetic Etiologies Are More Common Than Expected. Front Pediatr 2020;8:464. [PMID: 32903448 DOI: 10.3389/fped.2020.00464] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, Salzgeber K, Schmidt H, Schwab KO, Voss E, Wabitsch M, Wölfle J. Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Pediatr 2020;7:8. [PMID: 32647925 DOI: 10.1186/s40348-020-00100-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
144 Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, Salzgeber K, Schmidt H, Schwab KO, Voss E, Wabitsch M, Wölfle J. Genotyp-Phänotyp-Korrelationen bei Kindern und Jugendlichen mit nichtklassischem adrenogenitalen Syndrom mit 21-Hydroxylase-Defekt. Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-020-00976-y] [Reference Citation Analysis]
145 Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue. Clin Endocrinol 2019. [DOI: 10.1111/cen.14009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH. Crinecerfont Lowers Elevated Hormone Markers in Adults with 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021:dgab749. [PMID: 34653252 DOI: 10.1210/clinem/dgab749] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Lim E, Jeon JY. Congenital adrenal hyperplasia presenting as pelvic inflammatory disease in a phenotypic male: A case report. Medicine (Baltimore) 2020;99:e18387. [PMID: 31914016 DOI: 10.1097/MD.0000000000018387] [Reference Citation Analysis]
148 Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study. Clin Endocrinol (Oxf) 2020;92:284-94. [PMID: 31886890 DOI: 10.1111/cen.14149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
149 Huneif MA, Al Mutairi M, AlHazmy ZH, AlOsaimi FK, AlShoomi AM, AlGhofely MA, AlSaheel A. Screening for testicular adrenal rest tumors among children with congenital adrenal hyperplasia at King Fahad Medical City, Saudi Arabia. J Pediatr Endocrinol Metab 2021. [PMID: 34757702 DOI: 10.1515/jpem-2021-0291] [Reference Citation Analysis]
150 Nermoen I, Falhammar H. Prevalence and Characteristics of Adrenal Tumors and Myelolipomas in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Endocr Pract 2020;26:1351-65. [PMID: 33471666 DOI: 10.4158/EP-2020-0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
151 Gomes LG, Mendonca BB, Bachega TASS. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real? Curr Opin Endocrinol Diabetes Obes 2020;27:155-61. [PMID: 32304389 DOI: 10.1097/MED.0000000000000545] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
152 Van't Westeinde A, Karlsson L, Nordenström A, Padilla N, Lajic S. First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age. J Clin Endocrinol Metab 2020;105:dgaa340. [PMID: 32497228 DOI: 10.1210/clinem/dgaa340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
153 Crafa A, Condorelli RA, Cannarella R, Aversa A, Calogero AE, La Vignera S. Physical Examination for Endocrine Diseases: Does It Still Play a Role? J Clin Med 2022;11:2598. [PMID: 35566722 DOI: 10.3390/jcm11092598] [Reference Citation Analysis]
154 Chan GC, Guiffre D, Kim MS, Garingo A. Hyponatremia, Metabolic Acidosis, and Abnormal Newborn Screen in a Preterm Neonate. Neoreviews 2021;22:e767-9. [PMID: 34725141 DOI: 10.1542/neo.22-11-e767] [Reference Citation Analysis]
155 Nowotny H, Ahmed SF, Bensing S, Beun JG, Brösamle M, Chifu I, Claahsen van der Grinten H, Clemente M, Falhammar H, Hahner S, Husebye E, Kristensen J, Loli P, Lajic S, Reisch N; Endo ERN (MTG1). Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine 2021;71:586-94. [PMID: 33661460 DOI: 10.1007/s12020-021-02649-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
156 Ekbom K, Strandqvist A, Lajic S, Hirschberg AL, Falhammar H, Nordenström A. Assessment of medication adherence in children and adults with congenital adrenal hyperplasia and the impact of knowledge and self-management. Clin Endocrinol (Oxf) 2021;94:753-64. [PMID: 33346381 DOI: 10.1111/cen.14398] [Reference Citation Analysis]
157 Esquivel-Zuniga MR, Kirschner CK, McCartney CR, Burt Solorzano CM. Non-PCOS Hyperandrogenic Disorders in Adolescents. Semin Reprod Med 2022. [PMID: 35052005 DOI: 10.1055/s-0041-1742259] [Reference Citation Analysis]
158 Van Vliet G, Grosse SD. [Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program]. Med Sci (Paris) 2021;37:528-34. [PMID: 34003099 DOI: 10.1051/medsci/2021053] [Reference Citation Analysis]
159 Török D. Congenital Adrenal Hyperplasia. Exp Suppl 2019;111:245-60. [PMID: 31588535 DOI: 10.1007/978-3-030-25905-1_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
160 Concolino P, Paragliola RM. Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns. Mol Diagn Ther 2021;25:327-37. [PMID: 33710594 DOI: 10.1007/s40291-021-00520-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Xia Y, Shi P, Xia J, Zhang H, Xu L, Kong X. Novel mutations of the CYP17A1 gene in four Chinese 46,XX cases with partial 17a-hydroxylase/17,20-lyase deficiency. Steroids 2021;173:108873. [PMID: 34097983 DOI: 10.1016/j.steroids.2021.108873] [Reference Citation Analysis]
162 Morton A, Teasdale S. Physiological changes in pregnancy and their influence on the endocrine investigation. Clin Endocrinol (Oxf) 2022;96:3-11. [PMID: 34724247 DOI: 10.1111/cen.14624] [Reference Citation Analysis]
163 Gao Y, Wang O, Guan W, Wu X, Mao J, Wang X, Yu W, Nie M. Bone mineral density and trabecular bone score in patients with 21-hydroxylase deficiency after glucocorticoid treatment. Clin Endocrinol (Oxf) 2021;94:765-73. [PMID: 33301636 DOI: 10.1111/cen.14391] [Reference Citation Analysis]
164 Brener A, Lebenthal Y, Shtamler A, Levy S, Stein R, Fattal-Valevski A, Sagi L. The endocrine manifestations of spinal muscular atrophy, a real-life observational study. Neuromuscul Disord 2020;30:270-6. [PMID: 32273202 DOI: 10.1016/j.nmd.2020.02.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
165 Stuenkel CA, Gompel A, Davis SR, Pinkerton JAV, Lumsden MA, Santen RJ. Approach to the Patient with New Onset Secondary Amenorrhea: Is This Primary Ovarian Insufficiency? J Clin Endocrinol Metab 2021:dgab766. [PMID: 34693971 DOI: 10.1210/clinem/dgab766] [Reference Citation Analysis]
166 Speiser PW. Invited Commentary: A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2020;105:dgaa509. [PMID: 32777044 DOI: 10.1210/clinem/dgaa509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Tantirukdham N, Sahakitrungruang T, Chaisiwamongkol R, Pongpanich M, Srichomthong C, Assawapitaksakul A, Buasong A, Tongkobpetch S, Yeetong P, Shotelersuk V. Long-read Amplicon Sequencing of the CYP21A2 in 48 Thai Patients With Steroid 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 2022;107:1939-47. [PMID: 35363313 DOI: 10.1210/clinem/dgac187] [Reference Citation Analysis]
168 Whittle E, Falhammar H. Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. J Endocr Soc 2019;3:1227-45. [PMID: 31187081 DOI: 10.1210/js.2019-00136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
169 White PC. Emerging treatment for congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 2022;29:271-6. [PMID: 35283460 DOI: 10.1097/MED.0000000000000723] [Reference Citation Analysis]
170 Jha S, El-Maouche D, Marko J, Mallappa A, Veeraraghavan P, Merke DP. Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors. J Endocr Soc 2019;3:2290-4. [PMID: 31745525 DOI: 10.1210/js.2019-00227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
171 Hou L, Liang L, Lin S, Ou H, Liu Z, Huang S, Zhang L, Meng Z. Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China. Steroids 2019;151:108474. [PMID: 31446012 DOI: 10.1016/j.steroids.2019.108474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Lajic S, Karlsson L, Zetterström RH, Falhammar H, Nordenström A. The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients. Int J Neonatal Screen 2020;6:68. [PMID: 33117907 DOI: 10.3390/ijns6030068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
173 Bialk ER, Lasarev MR, Held PK. Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia. Int J Neonatal Screen 2019;5:33. [PMID: 33072992 DOI: 10.3390/ijns5030033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
174 Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020;11:493. [PMID: 32903805 DOI: 10.3389/fendo.2020.00493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
175 Goedegebuure WJ, Hokken-Koelega ACS. Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report. Horm Res Paediatr 2019;92:209-13. [PMID: 31390647 DOI: 10.1159/000501746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
176 Al-Rayess H, Addo OY, Palzer E, Jaber M, Fleissner K, Hodges J, Brundage R, Miller BS, Sarafoglou K. Bone Age Maturation and Growth Outcomes in Young Children with CAH Treated with Hydrocortisone Suspension. J Endocr Soc 2022;6:bvab193. [PMID: 35047717 DOI: 10.1210/jendso/bvab193] [Reference Citation Analysis]
177 Finkielstain GP, Vieites A, Bergadá I, Rey RA. Disorders of Sex Development of Adrenal Origin. Front Endocrinol (Lausanne) 2021;12:770782. [PMID: 34987475 DOI: 10.3389/fendo.2021.770782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Hoyer-Kuhn H, Huebner A, Richter-Unruh A, Bettendorf M, Rohrer T, Kapelari K, Riedl S, Mohnike K, Dörr HG, Roehl FW, Fink K, Holl RW, Woelfle J. Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry. Endocr Connect 2021;10:561-9. [PMID: 33909597 DOI: 10.1530/EC-21-0023] [Reference Citation Analysis]
179 Zaman A, Rothman MS. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies. Endocrinol Metab Clin North Am 2021;50:97-111. [PMID: 33518189 DOI: 10.1016/j.ecl.2020.12.002] [Reference Citation Analysis]
180 Salle L, Lachâtre D, Galinat S. An unexpected finding in a 46,XX patient with congenital adrenal hyperplasia. J Gynecol Obstet Hum Reprod 2021;50:102113. [PMID: 33744520 DOI: 10.1016/j.jogoh.2021.102113] [Reference Citation Analysis]
181 Jha S, Turcu AF, Sinaii N, Brookner B, Auchus RJ, Merke DP. 11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase Deficiency. J Endocr Soc 2021;5:bvaa192. [PMID: 33447690 DOI: 10.1210/jendso/bvaa192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Kinaan M, Hamidi O, Yau H, Courtney KD, Eraslan A, Simon K. Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer. J Endocr Soc 2021;5:bvaa158. [PMID: 33294761 DOI: 10.1210/jendso/bvaa158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Santoreneos R, Vakulin C, Ellul M, Rawlings L, Hardy T, Poplawski N. Recurrent pneumothorax in a case of tenascin-X deficient Ehlers-Danlos syndrome: Broadening the phenotypic spectrum. Am J Med Genet A 2022. [PMID: 35128805 DOI: 10.1002/ajmg.a.62674] [Reference Citation Analysis]
184 Baronio F, Ortolano R, Menabò S, Cassio A, Baldazzi L, Di Natale V, Tonti G, Vestrucci B, Balsamo A. 46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features. Int J Mol Sci 2019;20:E4605. [PMID: 31533357 DOI: 10.3390/ijms20184605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
185 Takasawa K, Kashimada K. Toward Improving the Transition of Patients With Congenital Adrenal Hyperplasia From Pediatrics to Adult Healthcare in Japan. Front Pediatr 2022;10:936944. [DOI: 10.3389/fped.2022.936944] [Reference Citation Analysis]
186 Pussard E, Travers S, Bouvattier C, Xue Q, Cosson C, Viengchareun S, Martinerie L, Lombès M. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency. The Journal of Steroid Biochemistry and Molecular Biology 2020;198:105553. [DOI: 10.1016/j.jsbmb.2019.105553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
187 Rosenberg AGW, Pater MRA, Pellikaan K, Davidse K, Kattentidt-Mouravieva AA, Kersseboom R, Bos-Roubos AG, van Eeghen A, Veen JMC, van der Meulen JJ, van Aalst-van Wieringen N, Hoekstra FME, van der Lely AJ, de Graaff LCG. What Every Internist-Endocrinologist Should Know about Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five Years of 'Internal Medicine for Rare Genetic Syndromes'. J Clin Med 2021;10:5457. [PMID: 34830739 DOI: 10.3390/jcm10225457] [Reference Citation Analysis]
188 Tschaidse L, Auer MK, Dubinski I, Lottspeich C, Nowotny H, Schmidt H, Gut N, Reisch N. Ectopic Prostate Tissue in the Uterine Cervix of a Female with Non-Classic Congenital Adrenal Hyperplasia-A Case Report. J Clin Med 2022;11:4307. [PMID: 35893397 DOI: 10.3390/jcm11154307] [Reference Citation Analysis]
189 Dubinski I, Bechtold Dalla-Pozza S, Bidlingmaier M, Reisch N, Schmidt H. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2021;34:1543-8. [PMID: 34523293 DOI: 10.1515/jpem-2021-0540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Balsamo A, Baronio F, Ortolano R, Menabo S, Baldazzi L, Di Natale V, Vissani S, Cassio A. Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant. Front Pediatr 2020;8:593315. [PMID: 33415088 DOI: 10.3389/fped.2020.593315] [Reference Citation Analysis]
191 Nordenström A, Lajic S, Falhammar H. Clinical outcomes in 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 2021;28:318-24. [PMID: 33741777 DOI: 10.1097/MED.0000000000000625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
192 Jha S, Turcu AF. Nonclassic Congenital Adrenal Hyperplasia: What Do Endocrinologists Need to Know? Endocrinol Metab Clin North Am 2021;50:151-65. [PMID: 33518183 DOI: 10.1016/j.ecl.2020.10.008] [Reference Citation Analysis]
193 Zhang L, Li P, Ou H, Liu Z, Sun Y, Song Q, Hou L, Huang S, Meng Z, Liang L. Gender roles and behavioral problems in children with 21-hydroxylase deficiency in Southern China. Steroids 2021;165:108754. [PMID: 33172829 DOI: 10.1016/j.steroids.2020.108754] [Reference Citation Analysis]
194 Daae E, Feragen KB, Waehre A, Nermoen I, Falhammar H. Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review. Front Behav Neurosci 2020;14:38. [PMID: 32231525 DOI: 10.3389/fnbeh.2020.00038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
195 Herath M, Langdahl B, Ebeling PR, Milat F. Challenges in the diagnosis and management of glucocorticoid-induced osteoporosis in younger and older adults. Clin Endocrinol (Oxf) 2021. [PMID: 34811782 DOI: 10.1111/cen.14637] [Reference Citation Analysis]
196 Collaer ML, Hines M. No Evidence for Enhancement of Spatial Ability with Elevated Prenatal Androgen Exposure in Congenital Adrenal Hyperplasia: A Meta-Analysis. Arch Sex Behav 2020;49:395-411. [DOI: 10.1007/s10508-020-01645-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
197 Villela TR, Barra CB, Belisário AR, Luizon MR, Simões E Silva AC, Silva IN. Glucocorticoid receptor Gene (NR3C1) Polymorphisms and Haplotypes in patients with congenital adrenal hyperplasia. Mol Cell Endocrinol 2021;536:111399. [PMID: 34298075 DOI: 10.1016/j.mce.2021.111399] [Reference Citation Analysis]
198 Ravichandran L, Korula S, Asha HS, Varghese D, Parthiban R, Johnson J, Ishwarya J, Shetty S, Cherian KE, Jebasingh F, Kapoor N, Pachat D, Mathai S, Simon A, Rajaratnam S, Paul TV, Thomas N, Chapla A. Allele-specific PCR and Next-generation sequencing based genetic screening for Congenital Adrenal Hyperplasia in India. Eur J Med Genet 2021;64:104369. [PMID: 34718183 DOI: 10.1016/j.ejmg.2021.104369] [Reference Citation Analysis]
199 Giavoli C, Iurlaro E, Morelli V, Rodari G, Ronchi A, Pietrasanta C, Pugni L, Tubiolo D, Properzi P, Pesenti A, Mantovani G, Ferrazzi E, Arosio M. Case Report: Late-Onset Congenital Adrenal Hyperplasia and Acute Covid-19 Infection in a Pregnant Woman: Multidisciplinary Management. Front Endocrinol (Lausanne) 2020;11:602535. [PMID: 33519712 DOI: 10.3389/fendo.2020.602535] [Reference Citation Analysis]
200 Xi W, Mao J, Li S, Zhao Y, Nie M, Yu B, Gao Y, Lu L, Wu X. Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Endocr Pract 2020;26:997-1002. [PMID: 33471705 DOI: 10.4158/EP-2019-0610] [Reference Citation Analysis]
201 Di Cosmo C, De Marco G, Agretti P, Ferrarini E, Dimida A, Falcetta P, Benvenga S, Vitti P, Tonacchera M. Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity. J Endocrinol Invest 2021. [PMID: 34850364 DOI: 10.1007/s40618-021-01711-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Kocova M, Anastasovska V, Falhammar H. Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine 2020;69:262-77. [PMID: 32367336 DOI: 10.1007/s12020-020-02323-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
203 Kavanaugh GL, Mohnach L, Youngblom J, Kellison JG, Sandberg DE; in collaboration with Accord Alliance. "Good practices" in pediatric clinical care for disorders/differences of sex development. Endocrine 2021;73:723-33. [PMID: 34021489 DOI: 10.1007/s12020-021-02748-4] [Reference Citation Analysis]
204 Auer MK, Paizoni L, Hofbauer LC, Rauner M, Chen Y, Schmidt H, Huebner A, Bidlingmaier M, Reisch N. Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 2020;204:105734. [PMID: 32784048 DOI: 10.1016/j.jsbmb.2020.105734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
205 Oliveira NM, Langer RD, Lemos-Marini SHV, Guerra-Júnior G, Gonçalves EM. Bioelectrical Impedance Phase Angle and Its Determinants in Patients with Classic Congenital Adrenal Hyperplasia. J Am Coll Nutr 2021;:1-8. [PMID: 33764276 DOI: 10.1080/07315724.2021.1895902] [Reference Citation Analysis]
206 Spencer D, Pasterski V, Neufeld SAS, Glover V, O'Connor TG, Hindmarsh PC, Hughes IA, Acerini CL, Hines M. Prenatal androgen exposure and children's gender-typed behavior and toy and playmate preferences. Horm Behav 2021;127:104889. [PMID: 33181133 DOI: 10.1016/j.yhbeh.2020.104889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Bangalore Krishna K, Kogan BA, Mazur T, Hoebeke P, Bogaert G, Lee PA. Individualized care for patients with intersex (differences of sex development): part 4/5.Considering the Ifs, Whens, and Whats regarding sexual-reproductive system surgery. J Pediatr Urol 2021;17:338-45. [PMID: 33691983 DOI: 10.1016/j.jpurol.2021.02.011] [Reference Citation Analysis]
208 Kurzyńska A, Skalniak A, Franson K, Bistika V, Hubalewska-Dydejczyk A, Przybylik-Mazurek E. Molecular analysis and genotype-phenotype correlations in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency from southern Poland - experience of a clinical center. Hormones (Athens) 2022;21:241-9. [PMID: 35079965 DOI: 10.1007/s42000-022-00348-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Brener A, Segev-Becker A, Weintrob N, Stein R, Interator H, Schachter-Davidov A, Israeli G, Elkon-Tamir E, Lebenthal Y, Eyal O, Oren A. HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS WITH NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA. Endocr Pract 2019;25:794-9. [PMID: 31013157 DOI: 10.4158/EP-2018-0617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
210 Kamrath C, Hartmann MF, Pons-Kühnemann J, Wudy SA. Urinary GC-MS steroid metabotyping in treated children with congenital adrenal hyperplasia. Metabolism 2020;112:154354. [PMID: 32916150 DOI: 10.1016/j.metabol.2020.154354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
211 Wong FCK, Chan AZ, Wong WS, Kwan AHW, Law TSM, Chung JPW, Kwok JSS, Chan AOK. Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature. Case Rep Endocrinol 2019;2019:9237459. [PMID: 31772787 DOI: 10.1155/2019/9237459] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
212 Held PK, Bialk ER, Lasarev MR, Allen DB. 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency. J Pediatr 2021:S0022-3476(21)01063-5. [PMID: 34780778 DOI: 10.1016/j.jpeds.2021.10.063] [Reference Citation Analysis]
213 Gehrmann K, Engels M, Bennecke E, Bouvattier C, Falhammar H, Kreukels BPC, Nordenstrom A, Reisch N, Gehrmann N, Stikkelbroeck NMML, Quinkler M, Claahsen-van der Grinten HL; dsd-LIFE group. Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency. J Endocr Soc 2019;3:1445-56. [PMID: 31317123 DOI: 10.1210/js.2019-00082] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
214 Alkhzouz C, Bucerzan S, Miclaus M, Mirea AM, Miclea D. 46,XX DSD: Developmental, Clinical and Genetic Aspects. Diagnostics (Basel) 2021;11:1379. [PMID: 34441313 DOI: 10.3390/diagnostics11081379] [Reference Citation Analysis]
215 Ilany J, Liu J, Welsch C, Reznik-wolf H, Levy-lahad E, Auchus RJ. Salt-Losing 21-Hydroxylase Deficiency Caused by Double Homozygosity for Two “Mild” Mutations. The Journal of Clinical Endocrinology & Metabolism 2021;106:e680-6. [DOI: 10.1210/clinem/dgaa875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Naiki Y, Miyado M, Shindo M, Horikawa R, Hasegawa Y, Katsumata N, Takada S, Akutsu H, Onodera M, Fukami M. AAV-mediated gene therapy for patients' fibroblasts, iPS cells, and a mouse model of congenital adrenal hyperplasia. Hum Gene Ther 2022. [PMID: 35838129 DOI: 10.1089/hum.2022.005] [Reference Citation Analysis]
217 Carvalho B, Marques CJ, Santos-Silva R, Fontoura M, Carvalho D, Carvalho F. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: An Update on Genetic Analysis of CYP21A2 Gene. Exp Clin Endocrinol Diabetes 2021;129:477-81. [PMID: 32131114 DOI: 10.1055/a-1108-1419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Ng SM, Stepien KM, Krishan A. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia. Cochrane Database Syst Rev 2020;3:CD012517. [PMID: 32190901 DOI: 10.1002/14651858.CD012517.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
219 Wisniewski AB, Tishelman AC. Psychological perspectives to early surgery in the management of disorders/differences of sex development: . Current Opinion in Pediatrics 2019;31:570-4. [DOI: 10.1097/mop.0000000000000784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
220 Navardauskaitė R, Banevičiūtė K, Songailienė J, Grigalionienė K, Čereškevičius D, Šukys M, Mockevicienė G, Smirnova M, Utkus A, Verkauskienė R. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia. Medicina (Kaunas) 2021;57:1035. [PMID: 34684072 DOI: 10.3390/medicina57101035] [Reference Citation Analysis]
221 Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Gonçalves EM, Guerra-Júnior G. Fat Distribution and Lipid Profile of Young Adults with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Enzyme Deficiency. Lipids 2021;56:101-10. [PMID: 32929736 DOI: 10.1002/lipd.12280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty. J Pediatr Endocrinol Metab 2019;32:1055-63. [PMID: 31573958 DOI: 10.1515/jpem-2019-0006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
223 Miao H, Yu Z, Lu L, Zhu H, Auchus RJ, Liu J, Jiang J, Pan H, Gong F, Chen S, Lu Z. Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review. Steroids 2019;150:108448. [DOI: 10.1016/j.steroids.2019.108448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
224 de Oliveira DM, Tura A, Vasques ACJ, Camilo DF, Lima MM, de Lemos-Marini SHV, Goncalves EM, Guerra-Junior G, Geloneze B. Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance. J Clin Endocrinol Metab 2021;106:e1574-85. [PMID: 33421070 DOI: 10.1210/clinem/dgab010] [Reference Citation Analysis]
225 Marino R, Garrido NP, Ramirez P, Notaristéfano G, Moresco A, Touzon MS, Vaiani E, Finkielstain G, Obregón MG, Balbi V, Soria I, Belgorosky A. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021;106:e2789-802. [PMID: 33482002 DOI: 10.1210/clinem/dgab033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Yau M, Jacob M, Orton S, Howell JD, Lekarev O, Vogiatzi MG, Poppas D, Nimkarn S, Lin-Su K. Perioperative stress dose steroid management of children with classical congenital adrenal hyperplasia: Too much or too little? J Pediatr Urol 2021:S1477-5131(21)00329-6. [PMID: 34266748 DOI: 10.1016/j.jpurol.2021.06.027] [Reference Citation Analysis]
227 Meinel J, Haverkamp T, Wünsche F, Richter-Unruh A. Establishment of Clinical and Lab Algorithms for the Identification of Carriers of Mutations in CYP21A2 - A Study of 365 Children and Adolescents. Exp Clin Endocrinol Diabetes 2021;129:492-9. [PMID: 32838438 DOI: 10.1055/a-1217-7169] [Reference Citation Analysis]
228 Hawley JM, Adaway JE, Owen LJ, Keevil BG. Development of a total serum testosterone, androstenedione, 17-hydroxyprogesterone, 11β-hydroxyandrostenedione and 11-ketotestosterone LC-MS/MS assay and its application to evaluate pre-analytical sample stability. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:741-52. [DOI: 10.1515/cclm-2019-0959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
229 Dabas A, Bothra M, Kapoor S. CAH Newborn Screening in India: Challenges and Opportunities. Int J Neonatal Screen 2020;6:E70. [PMID: 33239596 DOI: 10.3390/ijns6030070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 Held PK, Bird IM, Heather NL. Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy. Int J Neonatal Screen 2020;6:67. [PMID: 33117906 DOI: 10.3390/ijns6030067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Troger T, Sommer G, Lang-Muritano M, Konrad D, Kuhlmann B, Zumsteg U, Flück CE. Characteristics of growth in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency during adrenarche and beyond. J Clin Endocrinol Metab 2021:dgab701. [PMID: 34599587 DOI: 10.1210/clinem/dgab701] [Reference Citation Analysis]
232 Hamed SA, Attiah FA, Abd Elaal RF, Fawzy M. Behavioral assessment of females with congenital adrenal hyperplasia. Hormones (Athens) 2021;20:131-41. [PMID: 32740726 DOI: 10.1007/s42000-020-00232-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
233 Zhang Q, Zhan M, Wu H, Feng P, Jin X, Wan Z, Yan J, Zhang P, Ke P, Zhuang J, Zhou J, Han L, Huang X. Simultaneous quantitation of 17 endogenous adrenal corticosteroid hormones in human plasma by UHPLC-MS/MS and their application in congenital adrenal hyperplasia screening. Front Chem 2022;10:961660. [DOI: 10.3389/fchem.2022.961660] [Reference Citation Analysis]
234 Miolski J, Ješić M, Zdravković V. Congenital adrenal hyperplasia. Medicinski podmladak 2021;72:48-53. [DOI: 10.5937/mp72-31347] [Reference Citation Analysis]
235 Speiser PW, Chawla R, Chen M, Diaz-Thomas A, Finlayson C, Rutter MM, Sandberg DE, Shimy K, Talib R, Cerise J, Vilain E, Délot EC. Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States. Int J Neonatal Screen 2020;6:37. [PMID: 32832708 DOI: 10.3390/ijns6020037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
236 Sarathi V, Reddy A, Tirupati S, Jumkhawala K. Acton-Prolongatum Stimulated Blood Steroid Profile in Apparently Healthy Asian Indian Women of Reproductive-Age Group. Ind J Clin Biochem. [DOI: 10.1007/s12291-022-01039-7] [Reference Citation Analysis]
237 Neumann U, Braune K, Whitaker MJ, Wiegand S, Krude H, Porter J, Digweed D, Voet B, Ross RJM, Blankenstein O. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules. J Clin Endocrinol Metab 2021;106:e1433-40. [PMID: 32888021 DOI: 10.1210/clinem/dgaa626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
238 Rushworth RL, Chrisp GL, Torpy DJ. The use of medical identification jewellery in adults with adrenal insufficiency in Australia. Clin Endocrinol 2019. [DOI: 10.1111/cen.13985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
239 de Vries L, Lebenthal Y, Phillip M, Shalitin S, Tenenbaum A, Bello R. Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency. Front Endocrinol (Lausanne) 2019;10:698. [PMID: 31681171 DOI: 10.3389/fendo.2019.00698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
240 Güran T, Tezel B, Çakır M, Akıncı A, Orbak Z, Keskin M, Selver Eklioğlu B, Ozon A, Özbek MN, Karagüzel G, Hatipoğlu N, Gürbüz F, Çizmecioğlu FM, Kara C, Şimşek E, Baş F, Aydın M, Darendeliler F. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants. J Clin Res Pediatr Endocrinol 2020;12:287-94. [PMID: 32157855 DOI: 10.4274/jcrpe.galenos.2020.2019.0182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
241 Shimakawa U, Shigehara K, Kawabe Y, Ouchi K, Mori J. A Case of Salt-Wasting 21-Hydroxylase Deficiency With Resistance to Aldosterone due to Urinary Tract Infection. Cureus 2020;12:e11763. [PMID: 33409011 DOI: 10.7759/cureus.11763] [Reference Citation Analysis]
242 Burman P, Falhammar H, Waldenström E, Sundin A, Bitzén U. 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism 2021;106:e675-9. [DOI: 10.1210/clinem/dgaa870] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
243 Çetin T, Turan İ. Co-existence of Congenital Adrenal Hyperplasia and Familial Hypokalemic Periodic Paralysis due to CYP21A2 and SCN4A Pathogenic Variants. J Clin Res Pediatr Endocrinol 2021;13:362-6. [PMID: 33389921 DOI: 10.4274/jcrpe.galenos.2020.2020.0219] [Reference Citation Analysis]
244 El-Maouche D, Hannah-Shmouni F, Mallappa A, Hargreaves CJ, Avila NA, Merke DP. Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2019;91:247-55. [PMID: 31001843 DOI: 10.1111/cen.13996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 de Hora MR, Heather NL, Webster D, Albert BB, Hofman PL. Birthweight or Gestational Age Adjusted Second Tier LCMSMS Cut-offs Improve Newborn Screening for CAH in New Zealand. J Clin Endocrinol Metab 2021:dgab383. [PMID: 34058748 DOI: 10.1210/clinem/dgab383] [Reference Citation Analysis]
246 Hanna CA, Cummins A, Fox D. Babies born with ambiguous genitalia: Developing an educational resource for Australian midwives. Women Birth 2022:S1871-5192(22)00101-9. [PMID: 35697608 DOI: 10.1016/j.wombi.2022.05.007] [Reference Citation Analysis]
247 Sandberg DE, Vilain E. Decision making in differences of sex development/intersex care in the USA: bridging advocacy and family-centred care. The Lancet Diabetes & Endocrinology 2022;10:381-3. [DOI: 10.1016/s2213-8587(22)00115-2] [Reference Citation Analysis]
248 Swendiman RA, Coons BE, Alter CA, Bamba V, Nance ML, Vogiatzi MG. Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience. J Endocr Soc 2020;4:bvz004. [PMID: 32104750 DOI: 10.1210/jendso/bvz004] [Reference Citation Analysis]
249 Glassberg KI. Commentary to self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE). J Pediatr Urol 2021;17:366-7. [PMID: 34116928 DOI: 10.1016/j.jpurol.2021.02.026] [Reference Citation Analysis]
250 Schröder MAM, Turcu AF, O'Day P, van Herwaarden AE, Span PN, Auchus RJ, Sweep FCGJ, Claahsen-van der Grinten HL. Production of 11-oxygenated androgens by testicular adrenal rest tumors. J Clin Endocrinol Metab 2021:dgab598. [PMID: 34390337 DOI: 10.1210/clinem/dgab598] [Reference Citation Analysis]
251 Lim SG, Lee YA, Jang HN, Kong SH, Ahn CH, Kim SW, Shin CH, Kim JH. Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. Front Endocrinol (Lausanne) 2021;12:761258. [PMID: 34712205 DOI: 10.3389/fendo.2021.761258] [Reference Citation Analysis]
252 Miller WL. Tenascin-X-Discovery and Early Research. Front Immunol 2020;11:612497. [PMID: 33505400 DOI: 10.3389/fimmu.2020.612497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Raza J, Zaidi SZ, Warne GL. Management of disorders of sex development - With a focus on development of the child and adolescent through the pubertal years. Best Pract Res Clin Endocrinol Metab 2019;33:101297. [PMID: 31492626 DOI: 10.1016/j.beem.2019.101297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
254 Eugster EA. Update on Precocious Puberty in Girls. J Pediatr Adolesc Gynecol 2019;32:455-9. [PMID: 31158483 DOI: 10.1016/j.jpag.2019.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Li Z, Huang L, Du C, Zhang C, Zhang M, Liang Y, Luo X. Analysis of the Screening Results for Congenital Adrenal Hyperplasia Involving 7.85 Million Newborns in China: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:624507. [PMID: 33967952 DOI: 10.3389/fendo.2021.624507] [Reference Citation Analysis]
256 Boettcher C, Flück CE. Rare forms of genetic steroidogenic defects affecting the gonads and adrenals. Best Pract Res Clin Endocrinol Metab 2021;:101593. [PMID: 34711511 DOI: 10.1016/j.beem.2021.101593] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Improda N, Barbieri F, Ciccarelli GP, Capalbo D, Salerno M. Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency. Front Endocrinol (Lausanne) 2019;10:212. [PMID: 31031703 DOI: 10.3389/fendo.2019.00212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
258 Falhammar H, Frisén L, Hirschberg AL, Nordenskjöld A, Almqvist C, Nordenström A. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-Based National Cohort Study. J Clin Endocrinol Metab 2021:dgab712. [PMID: 34601607 DOI: 10.1210/clinem/dgab712] [Reference Citation Analysis]
259 Nelson HA, Joshi HR, Straseski JA. Mistaken Identity: The Role of Autoantibodies in Endocrine Disease. J Appl Lab Med 2022;7:206-20. [PMID: 34996091 DOI: 10.1093/jalm/jfab128] [Reference Citation Analysis]
260 Ali SR, Bryce J, Haghpanahan H, Lewsey JD, Tan LE, Atapattu N, Birkebaek NH, Blankenstein O, Neumann U, Balsamo A, Ortolano R, Bonfig W, Claahsen-van der Grinten HL, Cools M, Costa EC, Darendeliler F, Poyrazoglu S, Elsedfy H, Finken MJJ, Fluck CE, Gevers E, Korbonits M, Guaragna-Filho G, Guran T, Guven A, Hannema SE, Higham C, Hughes IA, Tadokoro-Cuccaro R, Thankamony A, Iotova V, Krone NP, Krone R, Lichiardopol C, Luczay A, Mendonca BB, Bachega TASS, Miranda MC, Milenkovic T, Mohnike K, Nordenstrom A, Einaudi S, van der Kamp H, Vieites A, de Vries L, Ross RJM, Ahmed SF. Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2021;106:e192-203. [PMID: 32995889 DOI: 10.1210/clinem/dgaa694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
261 Chatziaggelou A, Sakkas EG, Votino R, Papagianni M, Mastorakos G. Assisted Reproduction in Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2019;10:723. [PMID: 31708872 DOI: 10.3389/fendo.2019.00723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
262 Wright C, O'Day P, Alyamani M, Sharifi N, Auchus RJ. Abiraterone acetate treatment lowers 11-oxygenated androgens. Eur J Endocrinol 2020;182:413-21. [PMID: 32045360 DOI: 10.1530/EJE-19-0905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
263 Alla A, Draoui N, Rami I, Rouf S, Saadi H, Kamaoui I, Latrech H. A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence. Annals of Medicine and Surgery 2022;78:103673. [DOI: 10.1016/j.amsu.2022.103673] [Reference Citation Analysis]
264 Meena H, Jana M, Singh V, Kabra M, Jain V. Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment. Indian J Pediatr 2019;86:496-502. [PMID: 30697677 DOI: 10.1007/s12098-018-02848-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
265 Iervolino LL, Ferraz-de-Souza B, Martin RM, Costa FC, Miranda MC, Mendonça BB, Bachega TS. Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years. Osteoporos Int 2020;31:905-12. [PMID: 31897546 DOI: 10.1007/s00198-019-05268-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
266 Jun J, Song SH, Park S, Han JH, Kim KS. Surgical Outcomes of Clitoroplasty in Children with Congenital Adrenal Hyperplasia and Clitoral Hypertrophy: A 19-Year Experience of a Single Surgeon. Int J Environ Res Public Health 2021;18:11152. [PMID: 34769670 DOI: 10.3390/ijerph182111152] [Reference Citation Analysis]
267 Wang W, Han R, Yang Z, Zheng S, Li H, Wan Z, Qi Y, Sun S, Ye L, Ning G. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 2021;211:105899. [PMID: 33864926 DOI: 10.1016/j.jsbmb.2021.105899] [Reference Citation Analysis]
268 Elliott V, Waldrop SW, Wiromrat P, Carreau AM, Green MC. The Interaction of Obesity and Reproductive Function in Adolescents. Semin Reprod Med 2022. [PMID: 35562099 DOI: 10.1055/s-0042-1744495] [Reference Citation Analysis]
269 Guarnotta V, Niceta M, Bono M, Marchese S, Fabiano C, Indelicato S, Di Gaudio F, Garofalo P, Giordano C. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia. The Journal of Steroid Biochemistry and Molecular Biology 2020;198:105554. [DOI: 10.1016/j.jsbmb.2019.105554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
270 Conlon TA, Hawkes CP, Brady JJ, Murphy NP. The presentation of congenital adrenal hyperplasia in an unscreened population. J Pediatr Endocrinol Metab 2021;34:1123-9. [PMID: 34167176 DOI: 10.1515/jpem-2021-0123] [Reference Citation Analysis]
271 Ye L, Zhao Z, Ren H, Wang W, Zhou W, Zheng S, Han R, Zhang J, Li H, Wan Z, Tang C, Sun S, Wang W, Ning G. A multi-classifier system to identify and subtype congenital adrenal hyperplasia based on circulating steroid hormones. J Clin Endocrinol Metab 2022:dgac271. [PMID: 35512387 DOI: 10.1210/clinem/dgac271] [Reference Citation Analysis]
272 Armstrong K, Benedict Yap A, Chan-Cua S, Craig ME, Cole C, Chi Dung V, Hansen J, Ibrahim M, Nadeem H, Pulungan A, Raza J, Utari A, Ward P. We All Have a Role to Play: Redressing Inequities for Children Living with CAH and Other Chronic Health Conditions of Childhood in Resource-Poor Settings. Int J Neonatal Screen 2020;6:E76. [PMID: 33124614 DOI: 10.3390/ijns6040076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
273 Saito Y, Takasawa K, Gau M, Yamauchi T, Nakagawa R, Miyakawa Y, Sutani A, Hosokawa-Tsuji A, Takishima S, Matsubara Y, Morio T, Kashimada K. Adrenal suppression and anthropometric data at two years of age was not influenced by the initial hydrocortisone dose in patients with 21-hydroxylase deficiency. Clin Pediatr Endocrinol 2021;30:155-61. [PMID: 34629737 DOI: 10.1297/cpe.30.155] [Reference Citation Analysis]
274 Livadas S, Bothou C. Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach. Front Endocrinol (Lausanne) 2019;10:366. [PMID: 31244776 DOI: 10.3389/fendo.2019.00366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
275 Agnani H, Bachelot G, Eguether T, Ribault B, Fiet J, Le Bouc Y, Netchine I, Houang M, Lamazière A. A proof of concept of a machine learning algorithm to predict late-onset 21-hydroxylase deficiency in children with premature pubic hair. The Journal of Steroid Biochemistry and Molecular Biology 2022. [DOI: 10.1016/j.jsbmb.2022.106085] [Reference Citation Analysis]
276 Werneck G, Rodrigues EMR, Mantovani RM, Lane JSS, Silva IN. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia: 6 years of follow-up. J Pediatr Endocrinol Metab 2019;32:519-26. [PMID: 31075083 DOI: 10.1515/jpem-2018-0512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
277 Barrera FJ, Raygoza-Cortez K, García-Leal M, Brito JP, Singh Ospina NM, Rodríguez-Gutiérrez R. Are American follow-up recommendations in endocrinology actionable? A systematic review of clinical practice guidelines. Endocrine 2021;72:375-84. [PMID: 33475975 DOI: 10.1007/s12020-020-02592-y] [Reference Citation Analysis]
278 Lee DH, Kong SH, Jang HN, Ahn CH, Lim SG, Lee YA, Kim SW, Kim JH. Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency. Arch Osteoporos 2022;17:45. [PMID: 35258698 DOI: 10.1007/s11657-022-01090-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Mittnacht J, Choukair D, Breil T, Klose D, Inta I, Bettendorf M. Relation of health-related quality of life to near final height and body composition in adolescents with chronic endocrinopathies during transition period. Clin Endocrinol (Oxf) 2020;93:696-704. [PMID: 32682344 DOI: 10.1111/cen.14287] [Reference Citation Analysis]
280 Onuma S, Fukuoka T, Miyoshi Y, Fukui M, Satomura Y, Yasuda K, Kimura T, Tachibana M, Bessho K, Yamamoto T, Tanaka H, Katsumata N, Fukami M, Hasegawa T, Ozono K. Two girls with a neonatal screening-negative 21-hydroxylase deficiency requiring treatment with hydrocortisone for virilization in late childhood. Clin Pediatr Endocrinol 2021;30:143-8. [PMID: 34285457 DOI: 10.1297/cpe.30.143] [Reference Citation Analysis]
281 Lai F, Srinivasan S, Wiley V. Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme. Int J Neonatal Screen 2020;6:63. [PMID: 33117905 DOI: 10.3390/ijns6030063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
282 Umaña-Calderón A, Acuña-Navas MJ, Alvarado D, Jiménez M, Cavallo-Aita F. CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica. Mol Genet Metab Rep 2021;27:100728. [PMID: 33604243 DOI: 10.1016/j.ymgmr.2021.100728] [Reference Citation Analysis]
283 Lao Q, Mallappa A, Rueda Faucz F, Joyal E, Veeraraghavan P, Chen W, Merke DP. A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia. Mol Genet Genomic Med 2021;9:e1556. [PMID: 33332743 DOI: 10.1002/mgg3.1556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
284 Wyrwoll MJ, Rudnik-schöneborn S, Tüttelmann F. Genetic counseling and diagnostic guidelines for couples with infertility and/or recurrent miscarriage. Medizinische Genetik 2021;33:3-12. [DOI: 10.1515/medgen-2021-2051] [Reference Citation Analysis]
285 Karsli T, Jain VG, Mhanna M, Wu Q, Pepkowitz SH, Chandler DW, Shekhawat PS. Assessment of adrenal function at birth using adrenal glucocorticoid precursor to product ratios to predict short-term neonatal outcomes. Pediatr Res 2020;87:767-72. [PMID: 31645056 DOI: 10.1038/s41390-019-0629-8] [Reference Citation Analysis]
286 Hindmarsh PC, Honour JW. Would Cortisol Measurements Be a Better Gauge of Hydrocortisone Replacement Therapy? Congenital Adrenal Hyperplasia as an Exemplar. Int J Endocrinol 2020;2020:2470956. [PMID: 33299411 DOI: 10.1155/2020/2470956] [Reference Citation Analysis]
287 Nowotny HF, Auer MK, Lottspeich C, Schmidt H, Dubinski I, Bidlingmaier M, Adaway J, Hawley J, Keevil B, Reisch N. Salivary profiles of 11-oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2021:dgab446. [PMID: 34165575 DOI: 10.1210/clinem/dgab446] [Reference Citation Analysis]
288 Bidault V, Botto N, Paye-Jaouen A, Leger J, Josset-Raffet É, Martinerie L, Peycelon M, El-Ghoneimi A. New method for early evaluation of clitoris innervation using clitoro-perineal reflex after feminizing genitoplasty in early childhood: a pilot-study. Sci Rep 2021;11:7087. [PMID: 33782453 DOI: 10.1038/s41598-021-86434-5] [Reference Citation Analysis]
289 Schröder MAM, van Herwaarden AE, Span PN, van den Akker ELT, Bocca G, Hannema SE, van der Kamp HJ, de Kort SWK, Mooij CF, Schott DA, Straetemans S, van Tellingen V, van der Velden JA, Sweep FCGJ, van der Grinten HLC. Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2021:dgab826. [PMID: 34788830 DOI: 10.1210/clinem/dgab826] [Reference Citation Analysis]
290 Paizoni L, Auer MK, Schmidt H, Hübner A, Bidlingmaier M, Reisch N. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 2020;197:105540. [PMID: 31730799 DOI: 10.1016/j.jsbmb.2019.105540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
291 Papathomas TG, Sun N, Chortis V, Taylor AE, Arlt W, Richter S, Eisenhofer G, Ruiz-Babot G, Guasti L, Walch AK. Novel methods in adrenal research: a metabolomics approach. Histochem Cell Biol 2019;151:201-16. [PMID: 30725173 DOI: 10.1007/s00418-019-01772-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
292 Aveiro-Lavrador M, De Sousa Lages A, Barros L, Paiva I. Late diagnosis of classic congenital adrenal hyperplasia: long-term consequences during adulthood. Endocrinol Diabetes Metab Case Rep 2021;2021:EDM210032. [PMID: 33982662 DOI: 10.1530/EDM-21-0032] [Reference Citation Analysis]
293 Mak D, Akinseye L, Lahoti A, Diaz-thomas A. Abnormal Newborn Screen During a Pandemic. NeoReviews 2022;23:e212-5. [DOI: 10.1542/neo.23-3-e212] [Reference Citation Analysis]
294 Wang X, Wang Y, Ma D, Zhang Z, Li Y, Yang P, Sun Y, Jiang T. Neonatal Screening and Genotype-Phenotype Correlation of 21-Hydroxylase Deficiency in the Chinese Population. Front Genet 2020;11:623125. [PMID: 33552137 DOI: 10.3389/fgene.2020.623125] [Reference Citation Analysis]
295 Ernst MM, Gardner M, Mara CA, Délot EC, Fechner PY, Fox M, Rutter MM, Speiser PW, Vilain E, Weidler EM, Sandberg DE; The DSD-Translational Research Network Leadership Group and Psychosocial Workgroup. Psychosocial Screening in Disorders/Differences of Sex Development: Psychometric Evaluation of the Psychosocial Assessment Tool. Horm Res Paediatr 2018;90:368-80. [PMID: 30783028 DOI: 10.1159/000496114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
296 Aleissa M, Aloraini T, Alsubaie LF, Hassoun M, Abdulrahman G, Swaid A, Eyaid WA, Mutairi FA, Ababneh F, Alfadhel M, Alfares A. Common disease-associated gene variants in a Saudi Arabian population. Ann Saudi Med 2022;42:29-35. [PMID: 35112591 DOI: 10.5144/0256-4947.2022.29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Mallappa A, Merke DP. Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nat Rev Endocrinol. [DOI: 10.1038/s41574-022-00655-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
298 de Vries L, Baum M, Horovitz M, Phillip M, Barash G, Pinhas-Hamiel O, Lazar L. Management of Fully Pubertal Girls With Nonclassical Congenital Adrenal Hyperplasia: Glucocorticoids Versus Oral Contraceptives. Endocr Pract 2021:S1530-891X(21)01176-9. [PMID: 34438053 DOI: 10.1016/j.eprac.2021.08.005] [Reference Citation Analysis]
299 Ramirez Alcantara J, Halper A. Adrenal insufficiency updates in children. Curr Opin Endocrinol Diabetes Obes 2021;28:75-81. [PMID: 33278125 DOI: 10.1097/MED.0000000000000591] [Reference Citation Analysis]
300 Xia Y, Shi P, Gao S, Liu N, Zhang H, Kong X. Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 2022;222:106156. [PMID: 35882282 DOI: 10.1016/j.jsbmb.2022.106156] [Reference Citation Analysis]
301 Kariyawasam D, Nguyen-Khoa T, Gonzalez Briceño L, Polak M. [Newborn screening for congenital adrenal hyperplasia in France]. Med Sci (Paris) 2021;37:500-6. [PMID: 34003096 DOI: 10.1051/medsci/2021060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Dahl SR, Nermoen I, Brønstad I, Husebye ES, Løvås K, Thorsby PM. Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency. Endocr Connect 2018;7:1542-50. [PMID: 30530876 DOI: 10.1530/EC-18-0453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
303 Turcu AF, El-Maouche D, Zhao L, Nanba AT, Gaynor A, Veeraraghavan P, Auchus RJ, Merke DP. Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation. Eur J Endocrinol 2020;183:63-71. [PMID: 32487778 DOI: 10.1530/EJE-20-0129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
304 Lašaitė L, Navardauskaitė R, Semėnienė K, Verkauskienė R. Psychological stress, emotions, and quality of life in men and women with congenital adrenal hyperplasia. J Endocrinol Invest 2022. [PMID: 35612812 DOI: 10.1007/s40618-022-01824-4] [Reference Citation Analysis]
305 Long Q, Zhang T, Yan Y, Zhao H, Zhou W, Zeng J, Li S, Zhang J, Zeng Q, Zhao B, Zhang C, Chen W. Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods. Clin Chem Lab Med 2021;59:523-32. [PMID: 33554585 DOI: 10.1515/cclm-2020-0410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Al-Rayess H, Fleissner K, Jaber M, Brundage RC, Sarafoglou K. Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH. J Endocr Soc 2020;4:bvaa091. [PMID: 32803093 DOI: 10.1210/jendso/bvaa091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Speiser PW, Auchus RJ, Merke DP, Miller WL, White PC. Response to Letter to the Editor: "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab 2019;104:1928. [PMID: 30561699 DOI: 10.1210/jc.2018-02629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
308 Bacila I, Adaway J, Hawley J, Mahdi S, Krone R, Patel L, Alvi S, Randell T, Gevers E, Dattani M, Cheetham T, Kyriakou A, Schiffer L, Ryan F, Crowne E, Davies JH, Ahmed SF, Keevil B, Krone N. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism 2019;104:6417-29. [DOI: 10.1210/jc.2019-00031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
309 Pofi R, Prete A, Thornton-Jones V, Bryce J, Ali SR, Faisal Ahmed S, Balsamo A, Baronio F, Cannuccia A, Guven A, Guran T, Darendeliler F, Higham C, Bonfig W, de Vries L, Bachega TASS, Miranda MC, Mendonca BB, Iotova V, Korbonits M, Krone NP, Krone R, Lenzi A, Arlt W, Ross RJ, Isidori AM, Tomlinson JW. Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency. J Clin Endocrinol Metab 2020;105:dgz055. [PMID: 31613957 DOI: 10.1210/clinem/dgz055] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
310 Jahagirdar R, Khadilkar V, Deshpande R, Lohiya N. Clinical, Etiological and Laboratory Profile of Children with Disorders of Sexual Development (DSD)-Experience from a Tertiary Pediatric Endocrine Unit in Western India. Indian J Endocrinol Metab 2021;25:48-53. [PMID: 34386394 DOI: 10.4103/ijem.IJEM_520_20] [Reference Citation Analysis]
311 Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA. Height Velocity defined metabolic Control in Children with Congenital Adrenal Hyperplasia using urinary GC-MS Analysis. J Clin Endocrinol Metab 2019:jc. [PMID: 31112272 DOI: 10.1210/jc.2019-00438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
312 Ferreira MJ, Moita R, Canha M, Ferreira S, Costa C, Almeida P, Castedo JL, Carvalho D, Castro-Correia C. Quality of Life in Children Diagnosed With Non-classic Congenital Adrenal Hyperplasia. Cureus 2021;13:e18937. [PMID: 34812321 DOI: 10.7759/cureus.18937] [Reference Citation Analysis]
313 Fernández CS, Taboas M, Bruque CD, Benavides-Mori B, Belli S, Stivel M, Oneto A, Pasqualini T, Delea M, Espeche LD, Kolomenski JE, Alba L, Buzzalino N, Dain L. Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency. Clin Endocrinol (Oxf) 2020;93:19-27. [PMID: 32289882 DOI: 10.1111/cen.14190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Prentice P. Guideline review: congenital adrenal hyperplasia clinical practice guideline 2018. Arch Dis Child Educ Pract Ed 2021;106:354-7. [PMID: 33272921 DOI: 10.1136/archdischild-2019-317573] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
315 Harasymiw LA, Grosse SD, Sarafoglou K. Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents With Congenital Adrenal Hyperplasia. J Endocr Soc 2020;4:bvaa152. [PMID: 33195955 DOI: 10.1210/jendso/bvaa152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
316 Ntali G, Charisis S, Kylafi CF, Vogiatzi E, Michala L. The way toward adulthood for females with nonclassic congenital adrenal hyperplasia. Endocrine 2021;73:16-30. [PMID: 33855677 DOI: 10.1007/s12020-021-02715-z] [Reference Citation Analysis]
317 Nan MN, Roig R, Martínez S, Rives J, Urgell E, Espinós JJ, Tirado M, Carreras G, Aulinas A, Webb SM, Corcoy R, Blanco-Vaca F, Tondo M. Comprehensive Genetic Testing of CYP21A2: A Retrospective Analysis in Patients with Suspected Congenital Adrenal Hyperplasia. J Clin Med 2021;10:1183. [PMID: 33809035 DOI: 10.3390/jcm10061183] [Reference Citation Analysis]